Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

KTRA

Kintara Therapeutics (KTRA)

Kintara Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KTRA
DateTimeSourceHeadlineSymbolCompany
15/02/202509:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KTRAKintara Therapeutics Inc
08/02/202509:17Edgar (US Regulatory)Form S-4 - Registration of securities, business combinationsNASDAQ:KTRAKintara Therapeutics Inc
07/01/202508:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KTRAKintara Therapeutics Inc
07/01/202508:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KTRAKintara Therapeutics Inc
24/12/202409:00Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:KTRAKintara Therapeutics Inc
13/12/202401:07Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:KTRAKintara Therapeutics Inc
13/12/202401:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KTRAKintara Therapeutics Inc
26/11/202400:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KTRAKintara Therapeutics Inc
16/11/202409:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KTRAKintara Therapeutics Inc
15/11/202409:20Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:KTRAKintara Therapeutics Inc
15/11/202409:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KTRAKintara Therapeutics Inc
15/11/202408:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KTRAKintara Therapeutics Inc
26/10/202407:30Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:KTRAKintara Therapeutics Inc
26/10/202407:28Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:KTRAKintara Therapeutics Inc
26/10/202407:26Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:KTRAKintara Therapeutics Inc
26/10/202407:23Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:KTRAKintara Therapeutics Inc
26/10/202407:20Edgar (US Regulatory)Form SC 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:KTRAKintara Therapeutics Inc
23/10/202412:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KTRAKintara Therapeutics Inc
23/10/202411:50Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KTRAKintara Therapeutics Inc
23/10/202411:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KTRAKintara Therapeutics Inc
23/10/202411:44Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KTRAKintara Therapeutics Inc
23/10/202411:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KTRAKintara Therapeutics Inc
23/10/202411:38Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KTRAKintara Therapeutics Inc
23/10/202411:13Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KTRAKintara Therapeutics Inc
23/10/202411:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KTRAKintara Therapeutics Inc
23/10/202410:56Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KTRAKintara Therapeutics Inc
21/10/202423:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KTRAKintara Therapeutics Inc
17/10/202403:54PR Newswire (US)Kintara Therapeutics Announces Correction to Prior Announcement Regarding 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA Biosciences to Close on October 18, 2024NASDAQ:KTRAKintara Therapeutics Inc
17/10/202402:58PR Newswire (US)Kintara Therapeutics Announces 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA BiosciencesNASDAQ:KTRAKintara Therapeutics Inc
16/10/202415:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:KTRAKintara Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:KTRA